100% efficiency: a vaccine that protects against all coronaviruses and their strains has been created in the USA - ForumDaily
The article has been automatically translated into English by Google Translate from Russian and has not been edited.
Переклад цього матеріалу українською мовою з російської було автоматично здійснено сервісом Google Translate, без подальшого редагування тексту.
Bu məqalə Google Translate servisi vasitəsi ilə avtomatik olaraq rus dilindən azərbaycan dilinə tərcümə olunmuşdur. Bundan sonra mətn redaktə edilməmişdir.

Efficiency 100%: in the United States created a vaccine that protects against all coronaviruses and their strains

American scientists announced a breakthrough in the creation of a new type of vaccine against the coronavirus family, says "Voice of America".

Photo: Shutterstock

The first tests carried out on animals showed that the vaccine effectively suppressed the coronavirus. Moreover, not only COVID-19.

“We found in vaccinated animals that we could completely suppress SARS-COV-2,” says Kevin Sanders, a researcher at the Duke Human Vaccine Institute. “Unexpectedly for us, it also turned out that infection with other viruses associated with SARS was also suppressed.”

SARS, or Severe Acute Respiratory Syndrome Virus, belongs to a subset of diseases caused by coronaviruses. The relevance of the study is due to the fact that COVID-19 and similar infections tend to constantly mutate.

“Some of these mutated viruses are more contagious than others and cause more severe disease,” says Bart Haynes, director of the Duke Human Vaccine Institute. “Thus, the new coronavirus vaccine, if proven effective, will not only induce immune responses that protect against the original SARS-COV-2 virus, but also against mutated subtypes of the virus.”

The vaccine research institute at Duke University said that the vaccine they are creating is different from the Pfizer and Moderna, which have been released on the market, developed using coronavirus RNA.

On the subject: How many Americans get COVID-19 after being fully vaccinated: recent data

“This vaccine is made using a different technology. This is not a genetic vaccine like the RNA vaccines currently used in the first generation of COVID vaccinations,” Haynes explains.

According to the developers, the vaccine is based on a technology using nanoparticles that attack a specific receptor for the coronavirus spike protein, which binds the virus to a human cell. Thus, the proteins of the coronavirus become extremely vulnerable to cross-attacking antibodies produced by the human immune system. Scientists call the developed technology universal.

“We used the same nanoparticle vaccine design for SARS-COV-2 for the HIV vaccine. We literally swapped the components of the HIV vaccine and the SARS-COV-2 vaccine,” explains Kevin Sanders.

The mention of the HIV vaccine is no coincidence. Duke University emphasized that research and development of a vaccine against human immunodeficiency virus and coronavirus is taking place in parallel.

“All available HIV vaccine developments were used to urgently develop a vaccine against COVID-19,” says Haynes.

You may be interested in: top New York news, stories of our immigrants and helpful tips about life in the Big Apple - read it all on ForumDaily New York

Scientists are encouraged by animal tests. In tests on primates, whose immune system is believed to be closest to that of humans, the nanoparticle vaccine blocked COVID-19 infection by 100%.

“We have seen a high level of response in this study that has not been seen before with other vaccines,” Sanders said. “We found that the vaccine suppresses the multiplication of the virus in the nose. Many existing vaccines are not as effective as they are in the lungs at preventing the virus from multiplying in the nose. A virus that replicates in the nose can be more easily transmitted from one person to another. So it is necessary to suppress its reproduction in the same way as the spread of the virus in the lungs.”

Duke University says the vaccine is ready for human trials. They expect that if clinical tests are successful, their development could be useful for the next pandemic. The vaccine, as a constructor, can be adapted to a new type of coronavirus.

Read also on ForumDaily:

COVID-19 Vaccine Makers Become Billionaires: Their Money Would Be Enough To Inoculate All Poor Countries

In the USA, a cure for COVID-19 is now available to everyone: how it works

Horns will grow, autism or cancer will develop: the most popular myths-horror stories about vaccinations

Women massively complain about irregularities in the cycle after vaccination against COVID-19: is it dangerous

Miscellanea In the U.S.
Subscribe to ForumDaily on Google News

Do you want more important and interesting news about life in the USA and immigration to America? — support us donate! Also subscribe to our page Facebook. Select the “Priority in display” option and read us first. Also, don't forget to subscribe to our РєР ° РЅР ° Р »РІ Telegram  and Instagram- there is a lot of interesting things there. And join thousands of readers ForumDaily New York — there you will find a lot of interesting and positive information about life in the metropolis. 



 
1083 requests in 1,281 seconds.